Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Danner

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Genitourinary Medicine|April 1, 1996
Epidemiology of cryptosporidiosis among European AIDS patientsC Pedersen, S Danner, A Lazzarin, et al.
Transplantation Proceedings|April 1, 2008
Influence of rapamycin on rat macrophage viability and chemotaxis toward allogenic pancreatic islet supernatesS Danner, S Sigrist, F Moreau, et al.
The Journal of Infectious Diseases|August 1, 1997
Lamivudine-resistant human immunodeficiency virus type 1 variants (184V) require multiple amino acid changes to become co-resistant to zidovudine in vivoM Nijhuis, R Schuurman, D de Jong, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|January 1, 1996
Epidemiology of AIDS dementia complex in Europe. AIDS in Europe Study GroupA Chiesi, S Vella, L G Dally, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 1, 1995
Factors associated with the development of Pneumocystis carinii pneumonia in 5,025 European patients with AIDS. AIDS in Europe Study GroupJ D Lundgren, S E Barton, A Lazzarin, et al.
Lancet (London, England)|March 11, 1998
Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease. The Advanced HIV Disease Ritonavir Study GroupD W Cameron, M Heath-Chiozzi, S Danner, et al.
The Journal of Infectious Diseases|December 8, 1998
Conversion rate towards a syncytium-inducing (SI) phenotype during different stages of human immunodeficiency virus type 1 infection and prognostic value of SI phenotype for survival after AIDS diagnosisM Koot, R van Leeuwen, R E de Goede, et al.
AIDS (London, England)|April 16, 1998
The duration of viral suppression during protease inhibitor therapy for HIV-1 infection is predicted by plasma HIV-1 RNA at the nadirD J Kempf, R A Rode, Y Xu, et al.
European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes|September 6, 2012
Pancreatic carcinoma cell lines reflect frequency and variability of cancer stem cell markers in clinical tissueS Bünger, M Barow, C Thorns, et al.
HLA|June 27, 2018
Activating KIR Haplotype Influences Clinical Outcome Following HLA-Matched Sibling Hematopoietic Stem Cell TransplantationS L Heatley, C G Mullighan, K Doherty, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Genitourinary Medicine|April 1, 1996
Epidemiology of cryptosporidiosis among European AIDS patientsC Pedersen, S Danner, A Lazzarin, et al.
Transplantation Proceedings|April 1, 2008
Influence of rapamycin on rat macrophage viability and chemotaxis toward allogenic pancreatic islet supernatesS Danner, S Sigrist, F Moreau, et al.
The Journal of Infectious Diseases|August 1, 1997
Lamivudine-resistant human immunodeficiency virus type 1 variants (184V) require multiple amino acid changes to become co-resistant to zidovudine in vivoM Nijhuis, R Schuurman, D de Jong, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|January 1, 1996
Epidemiology of AIDS dementia complex in Europe. AIDS in Europe Study GroupA Chiesi, S Vella, L G Dally, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 1, 1995
Factors associated with the development of Pneumocystis carinii pneumonia in 5,025 European patients with AIDS. AIDS in Europe Study GroupJ D Lundgren, S E Barton, A Lazzarin, et al.
Lancet (London, England)|March 11, 1998
Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease. The Advanced HIV Disease Ritonavir Study GroupD W Cameron, M Heath-Chiozzi, S Danner, et al.
The Journal of Infectious Diseases|December 8, 1998
Conversion rate towards a syncytium-inducing (SI) phenotype during different stages of human immunodeficiency virus type 1 infection and prognostic value of SI phenotype for survival after AIDS diagnosisM Koot, R van Leeuwen, R E de Goede, et al.
AIDS (London, England)|April 16, 1998
The duration of viral suppression during protease inhibitor therapy for HIV-1 infection is predicted by plasma HIV-1 RNA at the nadirD J Kempf, R A Rode, Y Xu, et al.
European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes|September 6, 2012
Pancreatic carcinoma cell lines reflect frequency and variability of cancer stem cell markers in clinical tissueS Bünger, M Barow, C Thorns, et al.
HLA|June 27, 2018
Activating KIR Haplotype Influences Clinical Outcome Following HLA-Matched Sibling Hematopoietic Stem Cell TransplantationS L Heatley, C G Mullighan, K Doherty, et al.
Pageof 4